Host-derived matrix metalloproteinases (MMPs) and bacterial proteases mediate destruction of extracellular matrices and supporting alveolar bone in periodontitis. The Treponema denticola dentilisin protease induces MMP-2 expression and activation in periodontal ligament (PDL) cells, and dentilisin-mediated activation of pro-MMP-2 is required for cellular fibronectin degradation.
| INTRODUCTION
Periodontitis, a bacterially mediated chronic inflammatory disease of the tissues supporting the tooth is one of the most common inflammatory diseases in humans, and it can adversely affect systemic health (Armitage, 2004; Armitage, 2008) . National surveys show that the majority of adults suffer from mild-to-moderate periodontitis, with up to 15% of the population being affected by severe forms at some stage in their lives (Pihlstrom, Michalowicz, & Johnson, 2005) . Periodontitis causes largely irreversible destruction of the periodontal tissues, and in advanced stages, tooth loss, speech and masticatory problems, and an overall reduced quality of life. Moreover, the systemic burden of periodontitis on different organs has been investigated. It has been reported that periodontal infections can adversely predispose to coronary heart diseases (Stewart & West, 2016) , ischaemic strokes (Leira et al., 2016) , poor glycaemic control (Garcia, Tarima, & Okunseri, 2015) , preterm labour, low-birth-weight delivery (Sitholimela & Shangase, 2013) , and pulmonary diseases (Prasanna, 2011) . These systemic effects have been attributed to either direct bacterial invasion or modulation of specific host inflammatory and tissue destructive mediators (Williams et al., 2008) .
Destruction of the periodontal extracellular matrices (ECM) and detrimental changes in the cellular elements of the periodontal ligament (PDL) occur as a result of disruption of normal tissue homeostatic processes. One of these disrupted processes is regulation of host-derived matrix metalloproteinases (MMPs) that are both directly and indirectly involved in periodontal tissue breakdown.
Destruction of the ECM in periodontitis results in the release of fibronectin (FN) fragments, which are considered markers of periodontal disease status (Huynh et al., 2002) . Evidence from in vitro studies further indicate that these FN fragments induce several detrimental effects, including induction of apoptosis and suppression of osteoblast differentiation of PDL cells (Dai, Iwama, Wang, & Kapila, 2005; Ghosh, Park, Fenno, & Kapila, 2008; Jee, Wang, & Kapila, 2004; Joseph, Kapila, Hayami, & Kapila, 2010; Kapila, Kapila, & Johnson, 1996; Kapila, Lancero, & Johnson, 1998; Kapila, Wang, & Johnson, 1999) , thereby further potentiating disease progression.
MMPs are synthesised in latent form and then activated through proteolytic cleavage to expose the catalytic site of the MMP enzyme.
MMP activation is primarily extracellular, though intracellular activation is reported in certain cases (Murphy et al., 1999; Nagase, 1997) . MMPs are synthesised at low basal levels for maintenance of homeostatic processes; however, their levels and activation are typically increased during disease (Mittal et al., 2016) . In addition to their role in remodelling the ECM and basement membrane during various physiologic processes, MMPs are implicated in a wide range of pathologic processes, including cardiovascular (Azevedo, Prado, Antonio, Issa, & Gerlach, 2014) , pulmonary (Navratilova, Kolek, & Petrek, 2016; Pardo, Cabrera, Maldonado, & Selman, 2016) , renal (Aresu, Benali, Garbisa, Gallo, & Castagnaro, 2011; Charitaki et al., 2016) , and gastrointestinal diseases (Medina, Santana, Quintero, Radomski, & Guarner, 2004) , cancer (Endres et al., 2016 , Ligi & Mannello, 2016 , Lukaszewicz-Zajac, Szmitkowski, Litman-Zawadzka, & Mroczko, 2016 , Pietruszewska, BojanowskaPozniak, & Kobos, 2016 , and inflammatory diseases, such as periodontitis (Nissinen & Kahari, 2014; Shinkarenko, Rumiantsev, Egorova, & Eliseeva, 2013) .
MMP-2, one of several MMPs involved in tissue homeostasis
and remodelling, is constitutively expressed by PDL cells as pro-MMP-2 (Kapila et al., 1996) . Thus, control of the process or rate of activation of MMP-2 has been proposed as a key regulatory step in periodontal tissue homeostasis (Borkham-Kamphorst, Alexi, Tihaa, Haas, & Weiskirchen, 2015; Madsen et al., 2013; Mosig & Martignetti, 2013) . Activation of pro-MMP-2 is promoted by proteolytic cleavage by the membrane type-1-MMP (MT1-MMP/MMP-14; Murphy et al., 1999; Nagase, 1997; Zucker, Pei, Cao, & Lopez-Otin, 2003) . Extracellular MMP activities are controlled by the blockage of autolytic MMP activation or by endogenous proteinase inhibitors, such as tissue inhibitors of MMPs (TIMPs; Brew & Nagase, 2010; Nagase, Visse, & Murphy, 2006) . Regulation of the proteolytic activity of MMP-2 is dependent on the balance between MT1-MMP/ TIMP-2 (Hernandez-Barrantes, Shimura, Soloway, Sang, & Fridman, 2001; Oyarzun et al., 2010; Shofuda et al., 1998) . This mechanism of MMP-2 activation by an MT1-MMP-TIMP-2 complex has been well recognised in other systems (Butler et al., 1998; Kinoshita et al., 1998; Strongin et al., 1995) . Disturbances in that balance may result in excessive tissue degradation associated with inflammatory diseases (Ejeil et al., 2003) .
Treponema denticola along with Porphyromonas gingivalis and
Tannerella forsythia becomes prevalent in late stages of subgingival biofilm formation and comprises the bacterial "red complex" that is considered pathogenic in the aetiology of periodontal disease (Socransky, Haffajee, Cugini, Smith, & Kent Jr., 1998) . Although our understanding of the periodontal disease microbiome has greatly increased, the "red complex" bacteria continue to be recognised as important pathogens in the disease process. Oral spirochetes including T. denticola often predominate in periodontal disease, though they are typically below detectable levels in healthy gingival plaque (Choi, Paster, Dewhirst, & Gobel, 1994; Ellen & Galimanas, 2005) . The levels of T. denticola increase with the severity of periodontitis, underscoring its major role in the disease (Simonson, Goodman, Bial, & Morton, 1988; Yoshida et al., 2004) .
Recognised virulence factors of T. denticola include the acylated serine protease complex (dentilisin; PrtP complex; CTLP/chymotrypsin-like protease) that degrades gelatin, laminin, and various serum components and bioactive peptides (Grenier, Uitto, & McBride, 1990; Makinen, Makinen, & Syed, 1995; Uitto, Grenier, Chan, & McBride, 1988) . The dentilisin complex contributes to T. denticola adherence and cytotoxic effects on epithelial cells and fibroblasts (Ellen, Dawson, & Yang, 1994; Fenno et al., 1998; Mathers, Leung, Fenno, Hong, & McBride, 1996) and penetration of epithelial tissue (Chi, Qi, & Kuramitsu, 2003) , and it may play a role in complement-mediated bactericidal activity (McDowell, Huang, Fenno, & Marconi, 2009 ) and complement evasion (McDowell et al., 2011) . Of particular relevance to the current study, we previously demonstrated that dentilisin proteolytic activity induces activation of pro-MMP-2 in cultured PDL cells and that activated MMP-2 is required for cleavage of cellular FN into fragments similar to those observed in gingival crevicular fluid from periodontal lesions (Miao, Fenno, Timm, Joo, & Kapila, 2011) .
Furthermore, transcription and expression of MT1/MMP and TIMP-2 increased in response to T. denticola challenge (Miao et al., 2014) .
Taken together, these properties suggest important links between the T. denticola protease activity and regulation of the cellular and tissue processes that result in periodontal tissue destruction.
Epigenetics is defined as heritable and potentially reversible changes in gene expression without alterations in the DNA sequence (Goldberg, Allis, & Bernstein, 2007; Waddington, 2012) . Such modifications are not only associated with diseases but are also essential for the incorporation and integration of endogenous and environmental signals in cells. Epigenetic status can be affected by environmental factors, such as nutrients, toxins, infections, and hypoxia, with subsequent upregulation or downregulation of specific gene expression patterns (Barros & Offenbacher, 2009 , Bayarsaihan, 2011 , Safronova & Morita, 2010 , Yin & Chung, 2011 . Emerging evidence suggests that epigenetic modifications play a major role in inflammatory diseases, including periodontal disease (Barros & Offenbacher, 2014 Barros, & Beck, 2008; Pasquier, Hoarau-Vechot, Fakhro, Rafii, & Abi Khalil, 2015; Razzouk & Sarkis, 2013; Yin & Chung, 2011) . For example, chronically inflamed periodontal tissues demonstrated an increased methylation of CpG-rich regions of the PTGS2/COX2 promoter compared to healthy periodontal tissues (Zhang et al., 2010) . Also, there is marked hypomethylation of the IL8 promoter in oral epithelial cells of subjects with generalised aggressive periodontitis compared to control subjects (Andia et al., 2010) . Emerging studies suggest that microbial pathogens, including oral species such as P. gingivalis, induce epigenetic modifications in host cells (reviewed in Niller, Masa, Venkei, Meszaros, & Minarovits, 2017) . We recently identified potential epigenetic links between T. denticola and genes in PDL cells involved in activation of MMP-2 (Miao et al., 2014) . Thus, T. denticola may mediate epigenetic modifications that regulate MMP-2 activation and subsequent ECM degradation in the periodontium.
Epigenetic modifications are potentially reversible, and therefore, a thorough understanding of these changes may identify new therapeutic targets for disease management. The aim of this study was to investigate T. denticola's ability to chronically activate MMP expression through epigenetic modifications in PDL cells/tissues and to examine potential therapeutic approaches for reversal/modification of these changes.
2 | RESULTS 2.1 | T. denticola chronically upregulates expression of MMP-2, MT1-MMP, and TIMP-2, with concomitant FN fragmentation
To determine the long-term effects of a brief exposure to T. denticola on MMP-2 expression in host cells, PDL cells were briefly challenged with T. denticola, and then MMP-2 expression and MMP-2 activation in long-term cultures with daily medium changes were assessed by gelatin zymography and quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). As shown in Figure 1a , PDL cells constitutively expressed basal levels of pro-MMP-2 with minimal activation for maintenance of homeostatic functions. However, challenge with T. denticola triggered both chronic increased MMP-2 expression (pro-MMP2) and activation (active MMP-2) in PDL cells.
Following a 2-hr exposure to T. denticola, dentilisin activity (visible as a~100 kDa band on the zymogram, Figure 1a ) persisted within these cultures throughout the experiment, though it was detected at greatly reduced levels at Days 9 and 12. Expression and activation levels of MMP-2 were chronically sustained for up to 12 days, with minor reductions in the levels of activated MMP-2 on Days 9 and 12 ( Figure 1a) . T. denticola-mediated increases in MMP-2 expression and activation were mirrored by concomitant FN fragmentation throughout the experiment (Figure 1b) .
The chronic effects of T. denticola on MMP-2 expression in PDL cells were regulated at the transcriptional level. MMP-2 mRNA levels were upregulated for up to 12 days as assessed by qRT-PCR (Figure 1c) . Given that the MT1-MMP/TIMP-2 complex is a wellknown regulator of MMP-2 activation, MT1-MMP and TIMP-2 expression were examined in T. denticola challenged PDL cells in FIGURE 1 Treponema denticola mediates chronic expression and activation of MMP-2, MT1-MMP, and TIMP-2 in periodontal ligament (PDL) cells, with subsequent fragmentation of cellular fibronectin. Cultured PDL cells were challenged with T. denticola (Td) at multiplicity of infection = 100 or media control for 2 hr and then incubated for 3, 6, 9, and 12 days with daily medium changes. The experiments were repeated three times in triplicate. Data were analysed using one-way analysis of variance. (*) represents p ≤ .05 compared to the same time point in the control group. (#) represents p ≤ .001 compared to the same time point in the control group. (a) A representative gelatin zymogram of PDL cell conditioned medium showing the gelatinolytic activity of pro-MMP-2 (72-kDa), active MMP-2 (64-kDa), and Td dentilisin (100 kDa). The left four lanes represent the control unchallenged PDL cells, and the right four lanes represent the Td-challenged PDL cells. The bar chart below represents the densitometric analysis of gelatinolytic activity in the zymograms using ImageJ™-NIH software. The y axis represents fold-gelatinolytic activity of the pro-MMP-2, active MMP-2, and dentilisin relative to unchallenged control at 2.2 | T. denticola levels and MMP-2 transcription are elevated in periodontal disease Examination of human tissues from periodontally diseased and healthy sites confirmed the association between T. denticola and elevated MMP-2 expression in diseased tissues. Human tissue specimens from periodontally diseased sites exhibited elevated levels of T. denticola concomitant with elevated levels of MMP-2 mRNA expression compared with healthy sites (Figure 2 ). Tissue specimens from healthy sites exhibited negligible levels of T. denticola and low levels of MMP-2 expression. Low levels of MMP-2 expression in healthy tissues are consistent with the low basal levels of MMP-2 expression necessary for homeostatic functions within the periodontium, whereas increased MMP-2 expression is consistent with dysbiotic alterations of periodontal homeostasis in disease.
2.3 | Expression of genes encoding chromatin modification enzymes are significantly altered in periodontal disease
To further examine the role of epigenetics in periodontal disease, the major chromatin modification enzymes that might be involved in the disease process (Table S1) were assessed via a focused gene array.
Applying a "twofold change" as a threshold value, we found that several chromatin modification enzymes were significantly altered in diseased periodontal tissue specimens compared to healthy control tissues ( Figure 3a ,b and Table S2 ). The most significantly altered enzymes were the histone methyltransferases (HMTs) and histone deacetylases (HDACs), including PRMT8 and HDAC11, which exhibited a significant downregulation. Other enzymes, especially those related to SET domain proteins, histone acetyltransferases (HATs), and histone phosphorylation kinases showed significant upregulation, such as SETD4, ESCO1, ESCO2, and AURKB. Other significantly altered enzymes included HATs, HDACs, histone ubiquitinases, DNA demethylases, and histone demethylases (HDMs), and DNA methyltransferases (DNMTs).
| T. denticola significantly alters expression of genes encoding chromatin modification enzymes in PDL cells
To examine the potential role of epigenetics in the T. denticolamediated upregulation of MMP-2 expression, a focused gene array was employed to study all major epigenetic chromatin modification enzymes that might be involved in this process (Table S1 ). Applying a twofold change as a threshold value, we found that T. denticola- 2.5 | Inhibitors of histone kinase/aurora kinase, DNMT, and HDAC block T. denticola-mediated increases in MMP-2 activity and expression in PDL cells
Given the broad landscape of epigenetic changes mediated by T. denticola on PDL cells and the changes exhibited in diseased tissues, targeted approaches were employed to examine the role of representative members of each major class of epigenetic enzymes (Table 1) Examination of HDAC inhibitors apicidin and trichostatin revealed that pretreatment with these two inhibitors at the highest doses tested
(1 μM and 0.1 μM, respectively) also inhibited the T. denticolamediated increase in MMP-2 expression and activation as well as that of its activator complex, MT1-MMP/TIMP-2. However, as with EGCG, neither of these inhibitors affected FN fragmentation (data not shown).
| HMT, HDM, and HAT inhibitors exacerbate T. denticola-mediated increases in MMP-2 expression and activity in PDL cells
Inhibitors of HDMs, HMTs, and HATs were not effective in preventing the T. denticola-mediated increases in pro-MMP-2 expression and activation. Treatment with curcumin, a HAT inhibitor, resulted in moderately increased expression of pro-MMP-2, but significantly FIGURE 3 Transcription of multiple chromatin modification enzymes is altered in both periodontally diseased tissue and Treponema denticolachallenged periodontal ligament (PDL) cells. Transcription levels of 87 chromatin modification enzymes were examined by qRT-PCR using RNA extracted from healthy and diseased periodontal tissues (Panels (a) and (b), respectively) and from PDL cell lysates collected 9 days after Td challenge as described in Figure 1 2.7 | Inhibitors of histone phosphorylation and HDAC reverse T. denticola-mediated increases in MMP-2 activity and expression in PDL cells It is important to note that the results of the prechallenge and postchallenge inhibition experiments should not be compared in parallel because of different sample collection times used. In the pretreatment experiments, samples were collected after 3 days of a T. denticola (2-hr exposure) challenge, whereas in the postchallenge treatment experiments, the samples were collected 2 hr to 4 days after a T. denticola (2 hr exposure) challenge, depending on the inhibitor used. Similarly, in contrast to the prechallenge enzyme inhibition experiments, no decrease in FN fragmentation was observed in postchallenge inhibition experiments (data not shown), presumably because the MMP-2-mediated fragmentation process had begun before addition of enzyme inhibitors.
| DISCUSSION
ECM destruction, a key event in the pathogenesis of periodontitis, is mediated by host-derived enzymes such as MMP-2 that are involved in ECM homeostasis and remodelling. Strong evidence has accumulated over the past two decades that bacterial components, including proteases and lipopolysaccharides, are key factors contributing to dysregulation of ECM homeostasis. It is of particular interest that activation of pro-MMP-2, which is constitutively expressed in PDL cells, is required for the fragmentation of cellular FN that is typically seen in periodontal disease (Miao et al., 2011) . Thus, identifying factors that control MMP-2 expression or activation can help us better understand and modulate periodontal disease pathogenesis.
T. denticola is a member of a very complex microbiota involved in the pathogenesis of periodontal diseases. MMP-2 production and activation is a major event in the pathogenesis of these diseases via its role in extracellular matrix destruction. The T. denticola dentilisin protease plays an important role in the upregulation and activation of MMP-2 in PDL cells (Miao et al., 2011; Miao et al., 2014) Inhibition of DNA methyltransferases using epigallocatechin gallate (EGCG) mediates a decrease in MMP-2 activation, an increase in TIMP-2 transcription, and minimal decrease in fibronectin fragmentation in Td-challenged periodontal ligament (PDL) cells. Cultured PDL cells were pretreated with 5 or 10 μM EGCG for 2 days before being challenged with Treponema denticola (Td) at multiplicity of infection = 100 or media control for 2 hr and then incubated for 3 days. The conditioned medium and cell lysates were collected for zymography, Western blotting, and qRT-PCR. The experiments were repeated three times in triplicate. Data were analysed using one-way analysis of variance. Inhibition of different chromatin modification enzymes mediate alterations in levels of expression and activation of MMP-2 in Td-challenged and control periodontal ligament (PDL) cell cultures. PDL cells were pretreated with enzyme inhibitors at the indicated concentrations as follows: (a) curcumin (histone acetyltransferase inhibitor) for 2 hr, (b) 0.5 μM and 1 μM BIX-01294 (histone methyltransferase inhibitor) for 2 days, and (c) 2 μM and 5 μM tranylcypromine/TCP (histone demethylase inhibitor) for 4 days. The cells were then challenged with Treponema denticola (Td) at multiplicity of infection = 100 or media control for 2 hr and then incubated for 3 days. The conditioned medium and cell lysates were collected for zymography. Shown are densitometric analyses of pro-MMP-2 (72 kDa) and active MMP-2 (64 kDa) detected by gelatin zymography. The x axis represents different concentrations of enzyme inhibitors in the control and Td groups. The y axis represents fold-gelatinolytic activity of the pro-MMP-2 and active MMP-2 relative to unchallenged and untreated controls. (a) Curcurmin (Cr); (b) BIX-01294 (BIX); (c) tranylcypromine (TCP). The experiments were repeated three times in triplicate. Data were analysed using one-way analysis of variance. (*) represents p ≤ .05 compared to the "0" concentration in the same group. (#) represents p ≤ .001 compared to the "0" concentration in the same group Joseph et al., 2010; Kapila et al., 1996; Kapila et al., 1999; Kapila, Wang, Dazin, Tafolla, & Mass, 2002; Miao et al., 2011; Miao et al., 2014; Pereira et al., 2014; Tafolla, Wang, Wong, Leong, & Kapila, 2005) . The oral spirochete Treponema lecithinolyticum is also reported to activate MMP-2, as are P. gingivalis and Aggregatibacter actinomycetemcomitans (Chang, Yang, Lai, Liu, & Hsieh, 2002; Choi et al., 2001; Song et al., 2003) . The molecular mechanism(s) involved remain unstudied or unresolved for these species.
T. denticola dentilisin activity was present for several days in PDL cell conditioned medium, long after the brief (2 hr) challenge, washing and multiple changes of growth medium. This is consistent with our prior reports (Miao et al., 2011; Miao et al., 2014) and is likely due to persistent adherence of T. denticola to PDL cells, though we cannot yet rule out potential downstream effects of previously documented uptake of T. denticola by PDL cells (Miao et al., 2014) and gingival epithelial cells (Inagaki, Kimizuka, Kokubu, Saito, & Ishihara, 2016; Jo, Baek, Shin, & Choi, 2014; Shin & Choi, 2012) . Importantly, although dentilisin activity levels decreased steadily over time, MMP-2 and its activating complex, MT1-MMP and TIMP-2, were clearly expressed and activated through the 12th day of culture. These data confirm our previous results that dentilisin is an important factor in the activation of pro-MMP-2 (Miao et al., 2011) . Additionally, in FIGURE 8 Inhibitors of histone phosphorylases and deacetylases reverse Treponema denticola-mediated increases in MMP-2 activity and expression in periodontal ligament (PDL) cells. Cultured PDL cells were challenged with T. denticola (Td) at multiplicity of infection = 100 or media control for 2 hr, incubated for 3 days in serum-and antibiotic-free MEM-α with daily culture medium refreshment, and then treated with the following enzyme inhibitors: (a) 0.25 or 0.5 μM PF-03814735 (PF) for 2 days, (b) 0.5 or 1 μM apicidin for 1 day, and (c) 0.05 or 0.1 μM trichostatin A (TsA) for 4 days. The conditioned medium and cell lysates were collected for zymography, Western blotting, and qRT-PCR. The left portion of each panel shows densitometric analysis of pro-MMP-2 (72 kDa) and active MMP-2 (64 kDa) detected by gelatin zymography. The x axis represents different concentrations of the indicated inhibitor in the control and Td-challenged cultures. The y axis represents fold-gelatinolytic activity of the pro-MMP-2 and active MMP-2 relative to unchallenged and untreated controls. The right panel shows transcript levels of MMP-2, MT1-MMP, and TIMP-2 in the control and inhibitor-treated PDL cells as determined by qRT-PCR. The y axis represents fold-expression level of each gene relative to unchallenged and untreated controls. The x axis represents different concentrations of PF in the control and Td groups. The experiments were repeated three times in triplicate. Data were analysed using one-way analysis of variance. (*) represents p ≤ .05 compared to the "0" concentration in the same group. (#) represents p ≤ .001 compared to the "0" concentration in the same group agreement with our earlier findings (Miao et al., 2014) , the current data show that T. denticola chronically activates MMP-2, in concert with MT1-MMP and TIMP-2 expression up to 12 days. Importantly, degradation of cellular FN in PDL cell cultures is dependent on MMP-2 activation, which is the result of T. denticola dentilisin activity (Miao et al., 2011) . The persistent FN fragmentation in these samples may help explain the chronicity of tissue destruction mediated by bacterial proteases during periodontal disease pathogenesis.
Previous studies showed that T. denticola has the ability to adhere to and be internalised by several different host cells, including gingival epithelial cells, PDL cells, and polymorphonuclear leukocytes (Ding et al., 1997 , Konermann et al., 2012 , Miao et al., 2014 , Shin & Choi, 2012 . It should be noted that, unlike other oral pathogens, such as P. gingivalis that exhibits a cellular-invasive phenotype (Lamont et al., 1995) , there is no reported evidence that T. denticola survives in the intracellular environment. Taken in aggregate, these results and the findings from this study support the concept that the alteration of the PDL cells toward a destructive phenotype is a consequence of exposure to T. denticola. These data are consistent with evidence from other inflammatory diseases pointing toward an epigenetic role in the pathogenic process. We hypothesized that epigenetic mechanisms may imprint the periodontium and set in motion the process of chronic periodontal tissue destruction.
Mechanisms of epigenetic modifications include histone acetylation, histone methylation, DNA methylation, positioning of histone variants, and gene regulation by noncoding microRNAs (miRNAs; Bayarsaihan, 2016; Herceg, 2016; Perkins, Patel, Blanco, & Vogel, 2016) . Several enzymes are involved in these mechanisms including HATs, HDACs, HMTs, HDMs, histone phosphorylases, and DNMTs.
Perturbing the balance between acetylation/deacetylation and methylation/demethylation is profoundly associated with numerous diseases including developmental abnormalities and cancer and chronic inflammatory conditions (Barros & Offenbacher, 2009; Bird, 2002) . Epigenetic modifications are potentially reversible; therefore, a thorough understanding of these changes may identify new therapeutic targets for disease management. Using gene arrays that target chromatin modification enzymes, our data provide the first evidence that T. denticola mediates downregulation of many of these enzymes in PDL cells. In similar studies, P. gingivalis lipopolysaccharides were shown to downregulate many chromatin modification enzymes in cultured oral keratinocytes (de Camargo Pereira et al., 2013) and change the expression of multiple miRNAs in PDL cells (Du et al., 2016) . However, because T. denticola-dependent MMP-2 activation requires dentilisin proteolytic activity (Miao et al., 2011) , it is likely that the molecular mechanisms responsible for this downregulation differ from those driven by P. gingivalis lipopolysaccharides. Specific mechanisms by which T. denticola or its dentilisin protease may regulate epigenetic enzyme expression are under study in our laboratories.
The association between T. denticola and periodontitis has been reported in numerous studies (Asai, Jinno, Igarashi, Ohyama, & Ogawa, 2002; Sakamoto, Takeuchi, Umeda, Ishikawa, & Benno, 2001; Simonson et al., 1988; Yoshida et al., 2004) . Consistent with the existing literature, we found that T. denticola levels were significantly elevated in human tissue specimens from periodontally diseased sites compared with healthy sites, as measured by qPCR normalised to human glyceraldehyde-3-phosphate dehydrogenase (GAPDH; data not shown). To date, studies of the role of epigenetic modifications in periodontal disease have focused on DNA methylation patterns in genes involved in inflammatory responses (Barros & Offenbacher, 2014 ). The present study used gene array approaches to examine healthy and diseased periodontal tissues, revealing for the first time Inhibition of HDACs using apicidin and/or trichostatin was also effective in preventing or reversing the T. denticola-mediated effects on the expression of MMP-2 in PDL cells. Similar data were obtained by other studies investigating the effect of trichostatin on MMP-2 expression in murine fibroblasts (Ailenberg & Silverman, 2002) .
Trichostatin was further shown to decrease MMP-2 and MMP-9 expression in murine heart cells (Mani et al., 2015) and in human oesophageal squamous cell carcinoma cells (Wang et al., 2013 ).
Trichostatin, in combination with SAHA, was reported to inhibit the respiratory syncytial virus-mediated increase in HDAC2 expression with resultant decrease in airway inflammation and oxidative stress in vivo (Feng et al., 2016) . Apicidin was also reported to inhibit the expression of MMP-2 in different cancer cells (Ahn et al., 2012; Kim, Son, Kim, In Park, & Moon, 2000; Park et al., 2011) . On the other hand, inhibition of DNMTs using AZA showed a reduction in the expression of MMP-2 and its activating complex, whereas the use EGCG was not effective in this process.
Our results are consistent with those in other studies reporting that AZA causes a downregulation of MMP-2 and MMP-9 expression in cultured oesophageal squamous cell carcinoma cells (Liu, Sang, Hou, Zhang, & Shan, 2014) and breast cancer cells , respectively. AZA was approved by the U.S. Food and Drug Administration for treatment of myelodysplastic syndromes (Nebbioso, Carafa, Benedetti, & Altucci, 2012). It was also investigated in many clinical trials for treatment of several disorders, including haematological and neoplastic disorders (Chen, Huang, & Zha, 2012; Liu et al., 2005; Mirza, Sharma, Pandya, & Ralhan, 2010) . Regarding the effect of EGCG on MMP-2 expression in our study, the data are inconsistent with other studies, which reported the ability of EGCG to inhibit MMP-2 in different cancer cells , Nowakowska & Tarasiuk, 2016 . This inconsistency may be due to the use of different cell types, different concentrations of EGCG, or both. Concentrations higher than 10 μM were toxic to PDL cells as examined by cell proliferation and cytotoxicity assays (data not shown). Due to the weak effect of EGCG on the expression of MMP-2, we did not test its effects in a postchallenge scenario.
Negative consequences of using epigenetic enzyme inhibitors are possible, as seen in the current study. Specifically, some inhibitors, namely, those inhibiting HDM with TCP and those inhibiting HMT with BIX 01295, further increased MMP-2 expression and activation.
Although TCP and BIX are thought to mediate opposite actions, namely, BIX inhibits histone methylation and TCP promotes histone methylation, both increased MMP-2 expression and activation. Thus, due to these undesirable effects, BIX and TCP were not evaluated further in postchallenge scenarios. There are no previous studies investigating their effect on expression of MMPs. However, Pereira et al (2014) showed that increases in MMP-2 expression were stimulated by decreases in histone methylation in the context of the MMP-2 promoter. Additionally, in another study, the MMP-1, 3, 9, and 13 genes were shown to be actively transcribed in rheumatoid arthritis-derived synovial fibroblasts, and this transcription correlated with an elevation in H3K4me3 and suppression of H3K27me3 in the MMP promoter genes (Araki et al., 2016) . These studies, which both showed increases in MMP-2 expression despite different degrees of histone methylation, can be explained by the fact that activation or repression of gene expression by histone modifications/methylations depends on the type of lysine being modified and the degree of its methylation. For example, H3K4me, H3K36me, or H3K79me are associated with transcriptional activation (Barski et al., 2007; Guenther, Levine, Boyer, Jaenisch, & Young, 2007; Jenuwein & Allis, 2001; Koch et al., 2007; Kouzarides, 2007; Zhang & Reinberg, 2001) , whereas H3K9me, H3K27me, or H4K20me are implicated in gene repression (Barski et al., 2007; Jenuwein & Allis, 2001; Kouzarides, 2007; Nakayama, Rice, Strahl, Allis, & Grewal, 2001; Talbert & Henikoff, 2006) .
The HAT inhibitor curcumin also increased the expression of MMP-2 but significantly inhibited its activation. The effect of curcumin in decreasing MMP-2 and MMP-9 expression levels was reported in cancer cells, such as squamous cell carcinoma and osteoclastoma (Cao, Liu, Xu, Xu, & Feng, 2015; Lee et al., 2015) . Additionally, in vivo studies in humans and animals demonstrated curcumin's effectiveness in decreasing the severity of periodontal diseases (Bakir et al., 2016; Elburki et al., 2014; Elburki et al., 2016; Nagasri et al., 2015) . Curcumin has been investigated in many clinical trials for treatment of several disorders, such as ulcerative colitis (Baliga et al., 2012) , breast cancer (Nagaraju et al., 2012) , pancreatic cancer (Veeraraghavan et al., 2011) , and diabetes (Abdel Aziz et al., 2012) .
Additional investigation into the role of curcumin in MMP activation and regulation in periodontal diseases is further warranted, given these reports and the current study findings.
In summary, T. denticola plays a key role in the transcriptional regulation of MMP-2 and its activating complex MT1-MMP/TIMP-2 in PDL cells. T. denticola also mediates alterations of chromatin modification enzyme expression in PDL cells, and an array of epigenetic modifications are associated with periodontally diseased tissues. Furthermore, inhibition of enzymes that mediate epigenetic modifications can prevent T. denticola-mediated increases in MMP-2, MT1-MMP, and TIMP-2 in PDL cells. These inhibitors can also reverse the T. denticola-mediated effects on MMP-2 and its activating complex in PDL cells. These data indicate that T. denticola mediates its effects on MMP-2 activation through epigenetic modifications in these cells. This knowledge can be useful as a first step toward the development of novel targeted therapeutics for the treatment of periodontal diseases.
| EXPERIMENTAL PROCEDURES
4.1 | PDL cell culture As described previously, the primary culture of PDL cells was obtained via the direct cell outgrowth method by isolating cells from the PDL tissue around the middle third of extracted healthy human teeth (Scanlon, Marchesan, Soehren, Matsuo, & Kapila, 2011; Tanaka et al., 2011) . Cells were maintained in minimal essential medium-α (MEM-α) augmented with 10% fetal bovine serum, 1% penicillin/streptomycin (P/S), and 1% amphotericin B (Gibco, Grand Island, NY, USA) in a humid atmosphere with 95% air and 5% CO 2 at 37°C. Cell outgrowths were passaged when they reached confluency. Cells passaged three to six times were used for experimentation. The cell counting kit-8 4.4 | Challenge of PDL cells with T. denticola PDL cells were prepared in MEM-α free of serum and antibiotics. The bacteria in broth culture were collected by centrifugation, and then resuspended in serum-and antibiotic-free MEM-α to an optical density of 0.1 at 600 nm, such that the cellular density was approximately 2.4 × 10 8 cells/ml.
| Human periodontal tissues
T. denticola in serum-and antibiotic-free MEM-α was added to the test group of PDL cells (T. denticola group) at a multiplicity of infection (MOI) = 100, whereas only MEM-α was added to the control group. Both groups were then incubated for 2 hr at 37°C in 5% CO 2 -containing air. After the 2-hr challenge, PDL cells were washed three times with PBS and incubated for the planned time periods in serumand antibiotic-free MEM-α with daily medium changes as described previously (Miao et al., 2011) . Subsequently, the culture conditioned medium and cell lysates were collected, RNA was extracted from the cell lysates, and all samples were stored at −80°C for further investigations.
| Prechallenge inhibition of epigenetic chromatin modification enzymes in PDL cells
Different inhibitors of epigenetic chromatin modification enzymes (listed in Table 1) At the end of this incubation period, conditioned culture medium and cell lysates were harvested and stored at −80°C for further investigations.
| Postchallenge inhibition of epigenetic chromatin modification enzymes in PDL cells
For the postchallenge experiments, the PDL cells were first challenged with T. denticola as described before and then treated with the indicated concentrations of the inhibitors either as single agents or in combinations for certain periods. At the end of the treatment period, the conditioned culture medium and cell lysates were harvested and stored at −80°C for further investigations. All experiments were repeated at least three times, and each experiment was performed in triplicate.
| Gelatin zymography
Culture supernatants were concentrated approximately tenfold in Amicon centrifugal concentrators (10,000-molecular-weight cut-off;
Millipore), and total protein concentration was measured using the 
| Immunoblotting
Equivalent protein samples consisting of tenfold concentrates of PDL cell culture conditioned media were standardised as described above, subjected to standard SDS-PAGE (4-12% polyacrylamide gels;
Invitrogen, Carlsbad, CA, USA) and transferred to polyvinylidene difluoride (PVDF) membranes using standard techniques. The membranes were exposed to a rabbit polyclonal anti-FN IgG (Santa Cruz, Dallas, TX, USA) primary antibody diluted 1:2000 in Tris-buffered saline, 0.1% Tween 20 (TBST) solution for 2 hr at room temperature followed by a horseradish peroxidase-conjugated goat anti-rabbit IgG secondary antibody (Santa Cruz, Dallas, TX, USA) diluted 1:10,000 in TBST for 1 hr at room temperature with agitation. Western blots using anti-GAPDH antibodies were used to further confirm equal protein loading (data not shown). Blots were developed using the SuperSignal® West Pico kit (ThermoFischer Scientific, Pittsburgh, PA, USA) and scanned for digitization. GAPDH and compared to the control cells using the 2 −ΔΔCT method (Livak & Schmittgen, 2001) , applying a minimum twofold change in expression as the cut-off.
Similar methodology was utilised to assess the levels of MMP-2 transcription and the levels of T. denticola in human periodontal tissue samples. Periodontal tissue specimens were collected by scraping the most coronal portion of the tissue around the roots of extracted healthy and periodontally diseased teeth. Total RNA was extracted from healthy and diseased periodontal tissue specimens, and cDNA was generated. Target genes were amplified using TaqMan® Universal PCR Master Mix (Invitrogen, Carlsbad, CA, USA). Tissue sample human genome content was normalised using a custom TaqMan® primer/ probe set for GAPDH (Hs03929097_g1; Invitrogen, Carlsbad, CA, USA). T. denticola 16S rRNA was amplified in parallel using the SYBR® Green PCR Master Mix (Invitrogen, Carlsbad, CA, USA) with the following primer set: 16SrRNA-987F AGGGATATGGCAGCGTAGCA and 16SrRNA-1077R TTGCGGGACTTAACCCAACA.
| Quantitative reverse transcription (qRT-PCR) gene micro-array
qRT-PCR arrays were used to assess the transcriptional levels of the main epigenetic chromatin modification enzymes in cultured PDL cells and in periodontal tissues using the RT 2 Profiler PCR Array kit (Qiagen, Valencia, CA, USA) to assay transcription of the genes listed in Table   S1 . Periodontal tissue specimens were collected by scrapping the most coronal portion of the tissue around the roots of extracted healthy and periodontally diseased teeth. RNA was extracted and purified from PDL cell cultures using the RNeasy® Mini kit, whereas extraction and purification of RNA from periodontal tissues was achieved using T. denticola-challenged PDL cells was normalised to supplied housekeeping genes, β-actin, GAPDH, β-2-microglobulin, hypoxanthine phosphoribosyltransferase-1, and large ribosomal protein-P0, and then compared to expression levels in unchallenged PDL cells and the healthy tissues (Livak & Schmittgen, 2001 ).
| Statistical analysis
The data were analysed using the statistical software SPSS® v.22
(IBM, Armonk, NY, USA). Results were evaluated by a one-way analysis of variance when comparing more than two groups, whereas the Student's t test was used when comparing two groups. p ≤ .05 was considered significant, whereas p ≤ .001 was considered highly significant.
